Agenus to Host Conference Call to Discuss Global Licensing Agreement with Bristol Myers Squibb for Agenus’ Anti-TIGIT Bispecific Antibody Program
May 18, 2021 at 8:00 AM EDT
Supporting Materials
Download Presentation 229.3 KB
View Transcript 100.4 KB